Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Alzheimers Dis. 2009;17(4):807–815. doi: 10.3233/JAD-2009-1099

Table 1.

Sensitivity and specificity of medicare claims to identify dementia and Alzheimer’s diseasea

1a. Dementiab
ADAMS
Yes No Total
Medicare claims Raw % Weighted %
Yes 235 68 303 Sensitivity 85.5% 84.8%
Specificity 85.9% 89.2%
No 40 415 455 Positive predictive value 77.6% 56.0%
Negative predictive value 91.2% 97.3%
Total 275 483 758
1b. Alzheimer’s diseasec
ADAMS
Yes No Total
Medicare claims
Yes 126 49 175 Sensitivity 61.5% 64.2%
Specificity 91.1% 95.2%
No 79 504 583 Positive predictive value 72.0% 58.3%
Negative predictive value 86.4% 96.2%
Total 205 553 758

ADAMS = Aging, Demographics and Memory Study.

a

All types of Medicare claims records were used: inpatient, outpatient; part B physician supplier file; home health; Skilled Nursing Facility (SNF); hospice, and durable medical equipment. A code corresponding to Alzheimer’s disease or more generally dementia could appear in either the primary or secondary diagnosis position of a claim.

b

Dementia was noted by a series of codes used in past work, including ICD-9-CM code 331.0, Alzheimer’s disease.

c

Alzheimer’s disease was noted by the presence of ICD-9-CM code 331.0.